Outcomes | No. of studies | Sample size | iPACK + ACB vs ACB | I2 (%) | P | Publication bias (Egger's test) | Trim-and-fill Analysis | |||
---|---|---|---|---|---|---|---|---|---|---|
Mean difference 95%CI | t | P | 95%CI | |||||||
VAS score at rest (8 h post-op) | 7 | 614 | − 1.08 [− 1.47, − 0.70] | 89 | < 0.0001 | − 1.45 | 0.206 | − 46.86 | 13.03 | Stable |
VAS score at rest (12 h post-op) | 8 | 640 | − 1.00 [− 1.43, − 0.58] | 86 | < 0.0001 | − 2.76 | 0.033 | − 22.31 | − 1.33 | Stable |
VAS score at rest (24 h post-op) | 9 | 754 | − 0.56 [− 0.93, − 0.20] | 89 | 0.002 | − 1.57 | 0.16 | − 27.52 | 5.55 | Stable |
VAS score at rest (48 h post-op) | 10 | 874 | − 0.62 [− 0.96, − 0.26] | 93 | 0.0007 | − 3.08 | 0.015 | − 20.55 | − 2.93 | Stable |
VAS score at rest (at discharge) | 2 | 180 | − 0.10 [− 0.28, 0.09] | 0 | 0.31 | NA | NA | NA | NA | Stable |
VAS score at rest (overall) | 10 | 3062 | − 0.75 [− 0.96, − 0.53] | 94 | < 0.0001 |  |  |  |  |  |
VAS score with activity (8 h post-op) | 4 | 300 | − 0.83 [− 1.04, − 0.63] | 0 | < 0.0001 | 0.03 | 0.98 | − 27.98 | 28.34 | stable |
VAS score with activity (12 h post-op) | 6 | 460 | − 0.72 [− 1.09, − 0.34] | 79 | 0.0002 | − 1.52 | 0.204 | − 28.86 | 8.47 | stable |
VAS score with activity (24 h post-op) | 6 | 460 | − 0.53 [− 0.59, − 0.11] | 79 | 0.01 | − 2.04 | 0.111 | − 27.05 | 4.13 | Stable |
VAS score with activity (48 h post-op) | 6 | 460 | − 0.61 [− 1.00, − 0.23] | 78 | 0.002 | − 2.79 | 0.049 | − 26.04 | − 0.07 | Stable |
VAS score with activity (at discharge) | 2 | 180 | − 0.15 [− 0.37, 0.07] | 0 | 0.18 | NA | NA | NA | NA | Stable |
VAS score with activity (overall) | 6 | 1860 | − 0.61 [− 0.79, − 0.43] | 76 | < 0.0001 |  |  |  |  |  |
Cumulative morphine consumption (mg) | 5 | 439 | − 0.33 [− 0.52, − 0.14] | 0 | 0.0007 | − 0.56 | 0.617 | − 15.96 | 11.21 | Stable |
ROM on POD1 (degree) | 6 | 410 | 8.60 [5.13, 12.07] | 76 | < 0.0001 | 2.36 | 0.078 | − 2.49 | 30.55 | Stable |
ROM on POD2 (degree) | 7 | 550 | 8.04 [3.64, 12.44] | 90 | 0.0003 | 1.35 | 0.233 | − 9.54 | 30.82 | Stable |
ROM on POD3 (degree) | 4 | 324 | 5.56 [0.37, 10.76] | 84 | 0.04 | 4.38 | 0.048 | 0.23 | 24.62 | Stable |
ROM (overall) | 9 | 1284 | 7.69 [5.18, 10.21] | 86 | < 0.0001 |  |  |  |  |  |
TUG test on POD1 (s) | 4 | 353 | − 3.32 [− 5.57, − 1.06] | 18 | 0.004 | − 0.85 | 0.487 | − 23.08 | 15.49 | Stable |
TUG test on POD2 (s) | 3 | 269 | − 6.49 [− 12.02, − 0.96] | 58 | 0.02 | − 0.37 | 0.775 | − 131.5 | 124.09 | Stable |
TUG test at discharge (s) | 2 | 180 | − 0.88 [− 4.20, 2.45] | 0 | 0.61 | NA | NA | NA | NA | Stable |
TUG test (overall) | 5 | 832 | − 3.63 [− 5.74, − 1.52] | 43 | 0.0008 |  |  |  |  |  |
walk distance on POD1 (meters) | 5 | 439 | 0.23 [0.04, 0.41] | 0 | 0.02 | 2.27 | 0.107 | − 2.21 | 13.3 | Unstable |
Walk distance on POD2 (meters) | 4 | 320 | 0.21 [− 0.01, 0.43] | 0 | 0.06 | 5.01 | 0.038 | 1.1 | 14.47 | Stable |
Postoperative cumulative walk distance (meters) | 2 | 233 | 0.48 [0.15, 0.82] | 38 | 0.004 | NA | NA | NA | NA | Stable |
Walk distance (overall) | 7 | 992 | 0.28 [0.15, 0.41] | 2 | < 0.0001 |  |  |  |  |  |
Quadriceps muscle strength on POD1 | 4 | 320 | − 0.11 [− 0.24, 0.03] | 0 | 0.13 | − 1.49 | 0.276 | − 26.21 | 12.76 | Stable |
Quadriceps muscle strength on POD2 | 4 | 320 | − 0.04 [− 0.18, 0.09] | 0 | 0.52 | 0.5 | 0.669 | − 20.91 | 26.36 | Stable |
Postoperative quadriceps muscle strength (overall) | 4 | 640 | − 0.07 [− 0.17, 0.02] | 0 | 0.13 |  |  |  |  |  |
Hospital stays (hour) | 6 | 444 | − 0.47 [− 0.78, − 0.16] | 62 | 0.003 | − 2.57 | 0.062 | − 25.21 | 0.97 | Stable |
The incidence of PONV | 6 | 440 | 0.62 [0.35, 1.09] | 0 | 0.1 | − 6.9 | 0.002 | − 6.31 | − 2.69 | Stable |